Rapid quantitation of virus-neutralizing antibodies in biosamples - a novel BSL1 approach based on virus-like particles (VLPs)

Novel Myxopyronin Analogues and Myxopyronin Genecluster for Mutasynthesis

Cystobactamids – novel antibacterials against gram-negative pathogens

Innovative DOTA-Linkers for Bacterial Targeting

Novel Labyrinthopeptins as anti-viral agents

Increased Availability and Efficacy of Aminoglycosides

Chlorotonil as a Novel Antibiotic and Antiparasitic Therapeutic

Oral Antimotilin-Based Inhibitors for Treating Helicobacter pylori Infections

First-in-Class S. aureus α-Hemolysin Inhibitors for Lung and Skin Infections 

Phytosphingosine Derivatives as Adjuvants in Immune Stimulation

CRISPRdetect – multiplexed RNA detection with reprogrammed tracrRNAs

Overcoming resistance - Innovative broad-spectrum inhibitors of Metallo- β-lactamases

Best-In-Class P. aeruginosa LasB virulence factor Inhibitors

Best-in-class Darobactin derivate against Gram-negative Bacteria

Novel Lectin-Targeting therapeutics and diagnostics for Pseudomonas aeruginosa infections

Novel vaccine vector platform for safe and effective immunization using a replication-deficient murine cytomegalovirus (MCMV)

Novel inhibitors of Cytomegalovirus

Inhibitors of Energy Coupling Factor (ECF) Transporters Against Gram-Positive Pathogens

Rapid Detection of Shiga toxin producing E.coli (STEC) 

DeColi: Gut Decolonization of Multi-Resistant Escherichia coli

Novel ASO-Based mRNA Silencing Technology for Phage-Host Interaction Research

Non-Genetic Method for Controlling Biosynthetic Gene Cluster Operation

Jagaricin – a novel antifungal natural compound

Functionalized Nanoparticles for Viral Clearance

Targeting host lipid homeostasis to augment anti-mycobacterial treatment

Blood-based TB precision medicine: transcriptomic model for cure-associated treatment-end prediction

Blood-based TB precision medicine: transcriptomic model estimates time to culture conversion

Efficient, adjuvant-free mucosal vaccination via IgA feedback loop

Blood-based TB precision medicine: Flow-cytometric models for immunoprofiling and treatment monitoring

Novel treatment for sepsis in newborns

Broadly neutralizing antibodies against hepatitis E virus (HEV)

Functionally Selected HCV E2 Glycoproteins for a Broadly Protective Hepatitis C Vaccine

VSV-encoded HCV vaccines that induce broadly neutralising antibodies against Hepatitis C

Immunosuppressant resistance in anti-viral T cell products 

Broad-spectrum antiviral compounds against known and emerging viruses

HSV signature antibodies predict the development of anti-NMDA receptor encephalitis

EvolChip - A Convection-Driven Gradient Reactor for the Rapid Generation of Drug Concentration Gradients

RNA Sequence Motif for Agonists of the Human Toll-like Receptor 7 (TLR7)

Filtered Far-UV LED Device for Tissue-safe Antiseptic Decolonisation

NMR-Based Quantification and Glycoprofiling of Acute-Phase Glycoproteins from Native Blood Serum

The Prognostic Umbilical Swab: A Rapid Molecular Risk Stratification Tool for Neonatal Sepsis and Brain Injury

SARSeq: Multiplexed, parallel detection of SARS-CoV2 variants and other viruses in high-throughput

Two-Dimensional Redundant Dual Barcoding for Ultra-High-Throughput, Error-Resilient Nucleic Acid Analysis

Keratinophilic photosensitizers for the photodynamic therapy of onychomycosis